Literature DB >> 1613584

Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma.

A M Scott1, L Kostakoglu, J P O'Brien, D J Straus, H M Abdel-Dayem, S M Larson.   

Abstract

A case of primary thyroid lymphoma demonstrating uptake of 99mTc-hexakis-2-methoxy isobutyl isonitrile (MIBI) is presented. The 99mTc-MIBI image more clearly delineated the extent of tumor as demonstrated on CT compared to 201Tl-chloride and [99mTc]pertechnetate images. Following two courses of chemotherapy, repeat radionuclide studies and CT scan showed complete resolution of the thyroid tumor. Technetium-99m-MIBI may be useful in the assessment of disease activity and monitoring response to treatment in patients with lymphoma.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1613584

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  9 in total

1.  Demonstration of non-Hodgkin's lymphoma by dual radionuclide myocardial perfusion imaging.

Authors:  M C Cohen; J K Rastegar; R A DeSilva; T C Hill
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

2.  Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients.

Authors:  Radu Mihai; Fergus Gleeson; Ian D Buley; Derek E Roskell; Gregory P Sadler
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

3.  Accumulation of 99mTc-MIBI in bone marrow.

Authors:  C Jonsson; H Jacobsson
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

Review 4.  Technetium-99m methoxyisobutylisonitrile localizes an ectopic ACTH-producing tumour: case report and review of the literature.

Authors:  H Jacobsson; G Wallin; S Werner; S A Larsson
Journal:  Eur J Nucl Med       Date:  1994-06

5.  A miniaturized rapid paper chromatographic procedure for quality control of technetium-99m sestamibi.

Authors:  M Patel; S Sadek; S Jahan; A Owunwanne
Journal:  Eur J Nucl Med       Date:  1995-12

6.  Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.

Authors:  S Kosuda; H Yokoyama; M Katayama; T Yokokawa; S Kusano; O Yamamoto
Journal:  Eur J Nucl Med       Date:  1995-10

7.  Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.

Authors:  S Dadparvar; A Chevres; M Tulchinsky; L Krishna-Badrinath; A S Khan; W J Slizofski
Journal:  Eur J Nucl Med       Date:  1995-11

8.  Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi.

Authors:  G Baillet; L Albuquerque; Q Chen; M Poisson; J Y Delattre
Journal:  Eur J Nucl Med       Date:  1994-10

9.  Comparison of acquired cystic kidney disease between hemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  J H Park; Y O Kim; J H Park; B S Kim; S A Yoon; C W Yang; Y S Kim; C H Han; B S Kim; B K Bang
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.